Industry Strength Score
11/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
SARTORIUS STEDIM BIOTECH (56S1.DE) Stock Price & Overview
FRA:56S1 • FR0013154002
Current stock price
156.1 EUR
+4.6 (+3.04%)
Last:
The current stock price of 56S1.DE is 156.1 EUR. Today 56S1.DE is up by 3.04%. In the past month the price decreased by -8.93%. In the past year, price decreased by -18.01%.
56S1.DE Key Statistics
52-Week Range150.9 - 223.5
Current 56S1.DE stock price positioned within its 52-week range.
1-Month Range151.5 - 188.5
Current 56S1.DE stock price positioned within its 1-month range.
- Market Cap
- 15.193B
- P/E
- 31.16
- Fwd P/E
- 25.35
- EPS (TTM)
- 5.01
- Dividend Yield
- 0.44%
56S1.DE Stock Performance
Today
+3.04%
1 Week
-14.65%
1 Month
-8.93%
3 Months
-25.70%
Longer-term
6 Months -16.05%
1 Year -18.01%
2 Years -25.42%
3 Years -40.10%
5 Years N/A
10 Years N/A
56S1.DE Stock Chart
56S1.DE Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to 56S1.DE. When comparing the yearly performance of all stocks, 56S1.DE is a bad performer in the overall market: 91.99% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
56S1.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to 56S1.DE. Both the profitability and the financial health of 56S1.DE get a neutral evaluation. Nothing too spectacular is happening here.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
56S1.DE Earnings
On April 23, 2026 56S1.DE reported an EPS of 1.77 and a revenue of 761.50M. The company beat EPS expectations (44.69% surprise) and missed revenue expectations (-0.8% surprise).
Next Earnings DateJul 23, 2026
Last Earnings DateApr 23, 2026
PeriodQ1 / 2026
EPS Reported€1.77
Revenue Reported761.5M
EPS Surprise 44.69%
Revenue Surprise -0.80%
56S1.DE Forecast & Estimates
19 analysts have analysed 56S1.DE and the average price target is 240.56 EUR. This implies a price increase of 54.1% is expected in the next year compared to the current price of 156.1.
For the next year, analysts expect an EPS growth of 17.04% and a revenue growth 7.37% for 56S1.DE
Analysts
Analysts84.21
Price Target240.56 (54.11%)
EPS Next Y17.04%
Revenue Next Year7.37%
56S1.DE Financial Highlights
Over the last trailing twelve months 56S1.DE reported a non-GAAP Earnings per Share(EPS) of 5.01. The EPS increased by 31.84% compared to the year before.
Income Statements
Revenue(TTM)2.98B
Net Income(TTM)268.30M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.99% | ||
| ROA | 3.28% | ||
| ROE | 6.53% | ||
| Debt/Equity | 0.49 |
Chartmill High Growth Momentum
EPS Q2Q%52.59%
Sales Q2Q%2.27%
EPS 1Y (TTM)31.84%
Revenue 1Y (TTM)4.43%
56S1.DE Ownership
Ownership
Inst Owners11.99%
Shares97.33M
Float27.71M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
56S1.DE Industry Overview
56S1.DE operates in the Life Sciences Tools & Services sub-industry within the Health Care sector. This group contains 10 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
92/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
58%
Outperformed 58% of sub-industries
3 Month Rank
19%
Outperformed 19% of sub-industries
6 Month Rank
14%
Outperformed 14% of sub-industries
Industry Fundamentals & Breadth
- Members
- 10
- New Highs
- 0%
- New Lows
- 20%
- Average ROE
- 7%
- Average Profit Margin
- 8.2%
- Average Operating Margin
- 17.5%
- Average P/E
- 39.6
- Average Fwd P/E
- 25.5
- Average Debt/Equity
- 0.8
56S1.DE Competitors/Peers
The largest stocks on the EU markets in the "Life Sciences Tools & Services" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SRT3 | SARTORIUS AG-VORZUG | 32.39 | 16.264B | ||
| DIM | SARTORIUS STEDIM BIOTECH | 25.45 | 15.252B | ||
| SRT | SARTORIUS AG | 26.03 | 13.074B | ||
| QIA | QIAGEN N.V. | 13.05 | 5.983B | ||
| 1SXP | SCHOTT PHARMA AG& CO KGAA | 13.7 | 2.25B | ||
| EVT | EVOTEC SE | N/A | 932.091M | ||
| GXI | GERRESHEIMER AG | 9.7 | 847.612M | ||
| FF | FINE FOODS & PHARMACEUTICALS | 15.08 | 203.834M | ||
| MLC | MALIN CORP PLC | N/A |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 56S1.DE
Company Profile
The company is headquartered in Aubagne, Paca and currently employs 10,098 full-time employees.
Company Info
IPO: 1994-10-20
SARTORIUS STEDIM BIOTECH
Zone Industrielle les Paluds Avenue de Jouques, Bp 1051, Aubagne Cedex
Aubagne PACA FR
Employees: 10098
Phone: 33442845600
SARTORIUS STEDIM BIOTECH / 56S1.DE FAQ
What does SARTORIUS STEDIM BIOTECH do?
The company is headquartered in Aubagne, Paca and currently employs 10,098 full-time employees.
Can you provide the latest stock price for SARTORIUS STEDIM BIOTECH?
The current stock price of 56S1.DE is 156.1 EUR. The price increased by 3.04% in the last trading session.
Does 56S1 stock pay dividends?
SARTORIUS STEDIM BIOTECH (56S1.DE) has a dividend yield of 0.44%. The yearly dividend amount is currently 0.69.
How is the ChartMill rating for SARTORIUS STEDIM BIOTECH?
56S1.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What do analysts say about SARTORIUS STEDIM BIOTECH (56S1.DE) stock?
19 analysts have analysed 56S1.DE and the average price target is 240.56 EUR. This implies a price increase of 54.1% is expected in the next year compared to the current price of 156.1.
Is SARTORIUS STEDIM BIOTECH (56S1.DE) expected to grow?
The Revenue of SARTORIUS STEDIM BIOTECH (56S1.DE) is expected to grow by 7.37% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is SARTORIUS STEDIM BIOTECH worth?
SARTORIUS STEDIM BIOTECH (56S1.DE) has a market capitalization of 15.19B EUR. This makes 56S1.DE a Large Cap stock.